Cytosorbents

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cytosorbents and other ETFs, options, and stocks.

About CTSO

CytoSorbents Corp. engages in critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio includes CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. 

CEO
Phillip P. Chan
CEOPhillip P. Chan
Employees
149
Employees149
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1997
Founded1997
Employees
149
Employees149

CTSO Key Statistics

Market cap
71.88M
Market cap71.88M
Price-Earnings ratio
-3.05
Price-Earnings ratio-3.05
Dividend yield
—
Dividend yield—
Average volume
70.92K
Average volume70.92K
High today
$1.16
High today$1.16
Low today
$1.05
Low today$1.05
Open price
$1.05
Open price$1.05
Volume
69.57K
Volume69.57K
52 Week high
$1.61
52 Week high$1.61
52 Week low
$0.70
52 Week low$0.70
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.